Table 1.
Reference | Years | Countries | Experiment type | Sample size | LC-TB number | Time of follow-up | Contents |
---|---|---|---|---|---|---|---|
Aoki et al.128 | 1991 | Japan | Retrospective | 442 | 5 | \ | Five of 442 patients with LC developed active TB during LC treatment despite having latent TB. |
Chen et al.132 | 1996 | China | Retrospective | 3928 | 31 | 2 | Out of 3928 patients with LC, 31 individuals developed TB (tuberculosis). The risk of developing active TB was higher in patients with LC compared to the general population. Additionally, patients who developed active TB before or at the same time as their LC diagnosis experienced shorter survival times compared to those who did not develop TB (p = 0.007). |
Tamura et al.185 | 1999 | Japan | Retrospective | 25a | 3 | \ | Out of 25 patients with LC, one individual developed TB, resulting in a 1.9% incidence of active TB in patients with untreated LC. |
Watanabe et al.186 | 1999 | Japan | Retrospective | 758 | 6 | \ | Out of the 758 patients with cancer, 16 individuals had combined TB. Among these patients, 6 were found to have both TB and cancer. |
Remiszewski et al.133 | 2001 | Poland | Retrospective | 854 | 60 | \ | 60 of 845 patients with small cell LC died from active TB. |
Cicenas and Vencevicius187 | 2007 | Lithuania | Retrospective | 2218 | 46 | \ | Out of the 2,218 patients with LC, 46 individuals (2.1%) had coexisting LC and TB. |
Kim et al.126 | 2008 | Korea | Case-control | 3618 | 9 | 3 | The incidence of active TB was found to be 3.07 cases per 1000 person-years in patients with cancer, while it was 0.77 cases in controls. This difference was statistically significant with a p value of 0.009. Patients with cancer had an increased risk of developing TB compared to controls, with an incidence rate ratio (IRR) of 4.69 (95% CI: 1.52–14.46). |
Cha et al.130 | 2009 | Korea | Retrospective | 108 | 36 | \ | Out of the patients with LC, 10 individuals (27.8%) were diagnosed with TB at the same time as the diagnosis of LC, while 26 individuals (72.2%) were diagnosed with TB after the diagnosis of LC. The median time from LC diagnosis to TB diagnosis was 4 months, with a range of 1–47 months. |
Silva et al.129 | 2013 | Portugal | Retrospective cross-sectional | 24b | 10 | \ | Out of the cases diagnosed with both TB and LC, 10 were diagnosed simultaneously, meaning they received the diagnoses at the same time. In 14 cases, TB was diagnosed before the diagnosis of LC. The median time between the diagnoses of TB and LC was 5 years, with an interquartile range of 1–30 years. |
Suzuki et al.131 | 2016 | Japan | Observational | 904 | 9 | 2 | During the observation period, 9 out of 904 patients with cancer (1.00%) developed TB. In all cases, the occurrence of TB disease was within 2 years of the cancer diagnosis. The cumulative incidence of TB disease at 6 months was 0.65%, at 1 year it was 1.15%, and at 2 years it was 1.38%. |
Şimşek et al.188 | 2017 | turkey | Retrospective | 3101 | 11 | \ | Out of the total cases of LC and TB, 17 cases were diagnosed with both combined MTB or NTM and LC. These cases accounted for 1.2% of the total LC cases and 0.9% of the total TB cases. Among these 17 cases, in 11 of them (64.8%), MTB was identified as Mycobacterium bovis. |
Cukic V.11 | 2017 | Bosnia | Retrospective | 2608 | 34 | \ | 34 of 2,608 patients with LC, or 1.3%, were diagnosed with tb alone. |
Tamura et al.189 | 2020 | Japan | Retrospective | 1450 | 7 | 2 | Among the patients with LC, seven had active TB, 45 had previous TB, and 1,398 had neither active nor previous TB. Among the 1,398 patients without active or previous TB, 795 (57%) underwent an IGRA test, and of those, 120 (15%) were diagnosed with LTBI. This data indeed suggests that active TB is an important complication among patients with Japanese LC. |
Liao et al.127 | 2023 | China | Retrospective cohort | 71793 | 1335 | 1,335 cases of TB were identified among 71,793 patients with LC. The incidence of TB increased with age, and men had a significantly higher risk of developing TB than women, with an incidence rate ratio of 1.7 (95% CI: 1.5–2.0). Patients aged 60–69 years (HR: 1.4; 95% CI: 1.1–1.8) and those ≥70 years (HR: 1.9; 95% CI: 1.5–2.4) had a higher risk of TB than those younger than 50 years. Patients with a history of pneumoconiosis and those treated with surgery and chemotherapy also had a significantly increased risk of developing TB. |
The sample size consisted of the number of cases in clinical records with lung cancer complicated with pulmonary tuberculosis. However, there were 2 cases of active pulmonary tuberculosis diagnosed concurrently with lung cancer, and only 1 case of active pulmonary tuberculosis was found after the diagnosis of lung cancer.
The sample size consisted of the number of cases in clinical records with lung cancer complicated with pulmonary tuberculosis. However, only 10 cases of active pulmonary tuberculosis were found after the diagnosis of lung cancer, and the rest were discovered before the diagnosis of lung cancer.